Arcadia Biosciences Inc (RKDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 1,302 | 1,455 | 1,200 | 1,215 | 1,537 |
| Cost of Goods | 884 | 824 | 682 | 827 | 1,032 |
| Gross Profit | 418 | 631 | 518 | 388 | 505 |
| Operating Expenses | 2,454 | 1,956 | 670 | 3,495 | 2,297 |
| Operating Income | -1,152 | -501 | 530 | -2,280 | -1,760 |
| Other Income | 2,008 | -3,957 | 2,069 | -1,750 | 578 |
| Pre-tax Income | 856 | -4,458 | 2,599 | -4,030 | -1,182 |
| Net Income Continuous | 856 | -4,458 | 2,599 | -4,038 | -1,182 |
| Net Income Discontinuous | N/A | N/A | N/A | -26 | -430 |
| Net Income | $856 | $-4,458 | $2,599 | $-4,064 | $-1,612 |
| EPS Basic Total Ops | 0.63 | -3.26 | 1.90 | -2.99 | -1.18 |
| EPS Basic Continuous Ops | 0.63 | -3.26 | 1.90 | -2.96 | -0.87 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | -0.02 | -0.32 |
| EPS Diluted Total Ops | 0.62 | -3.26 | 1.90 | -2.99 | -1.18 |
| EPS Diluted Continuous Ops | 0.62 | -3.26 | 1.90 | -2.96 | -0.87 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | -0.02 | -0.32 |
| EPS Diluted Before Non-Recurring Items | 0.62 | 0.02 | 1.90 | N/A | -0.87 |
| EBITDA(a) | $-1,145 | $-473 | $578 | $-2,176 | $-1,664 |